SNAC uses structural and advanced image analysis to further the understanding of neurological disorders, and develop tailored imaging biomarkers for clinical trials of emerging therapeutics.
The recent incorporation of AI into SNAC’s research pipelines, rapidly accelerate the development of neuroimaging ‘smarts’ for both clinical trials and the diagnostic imaging industry.
SNAC values the open sharing of scientific knowledge. We regularly publish the findings of our research in respected journals and contribute to international academic meetings such as MICCAI, ISMRM, and ECTRIMS. We have deep collaborations with academics at the University of Sydney’s Brain and Mind Centre and with other imaging centres across the globe.